LEN-B vs PSNYW
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
Lennar Corporation exhibits a strong deterministic health profile with a Piotroski F-Score of 7/9 and an exceptionally clean balance sheet (Debt/Equity 0.25). While the stock is significantly undervalued relative to its Graham Number ($117.86), it is currently plagued by severe fundamental deterioration, with earnings plummeting over 50% YoY. The disconnect between strong solvency and crashing growth, coupled with a 0/100 technical trend, suggests a value trap scenario in the short term despite long-term defensive viability.
The deterministic health profile is critically weak, highlighted by a Piotroski F-Score of 3/9 and a complete absence of a Graham Number due to negative earnings and equity. The company is facing a severe liquidity crisis with a current ratio of 0.43 and a quick ratio of 0.21, indicating an inability to meet short-term obligations. Most alarmingly, the gross margin is -32.68%, meaning the company loses money on every vehicle produced before operating expenses. While revenue growth remains positive at 26.10%, the negative Price/Book ratio (-0.06) and bearish technical trend (0/100) suggest a high risk of insolvency or massive dilution.
Compare Another Pair
Related Comparisons
LEN-B vs PSNYW: Head-to-Head Comparison
This page compares Lennar Corporation (LEN-B) and Polestar Automotive Holding UK PLC (PSNYW) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.